The Bausch & Lomb Zyoptix Tissue Saving Aspheric algorithm
DeviceUsed with LASIK treatment for the correction of myopia and myopic astigmatism.
NCT Number: NCT00365677
The objective of this study was to compare the safety and effectiveness of two versions of the Bausch & Lomb Zyoptix Tissue Saving Aspheric Algorithm versus the current Zyoptix Tissue Saving Algorithm when used for myopia and myopic astigmatism LASIK treatment.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Used with LASIK treatment for the correction of myopia and myopic astigmatism.
Used with LASIK treatment for the correction of myopia and myopic astigmatism.
Time frame: At 90 days post surgery
Time frame: At 90 days post surgery
Time frame: At 90 days post surgery
Time frame: At 90 days post surgery
Looking for future studies?
Notify MeBausch & Lomb Incorporated
Industry
Compare the Safety and Effectiveness of Two Versions of the Bausch & Lomb Zyoptix™ Tissue Saving Aspheric Algorithm to the Current Zyoptix™ Tissue Saving Algorithm When Used for Myopia and Myopic Astigmatism Lasik Treatment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05320042
Astigmatism, Eye Diseases
Rochester, New York, United States
View Trial DetailsNCT07284966
Astigmatism, Eye Diseases
San Diego, California, United States
View Trial DetailsNCT06873048
Astigmatism, Eye Diseases
Waterloo, Ontario, Canada
View Trial DetailsNCT04200898
Astigmatism, Eye Diseases
Zagreb, City of Zagreb, Croatia
View Trial Details